VERO
Venus Concept Inc.
NASDAQ · Healthcare · Medical - Devices · CA
$0.31
+2.64%Income statement
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 58.9M | 64.8M | 76.4M | 99.5M | 105.6M |
| Cost of Revenue | 21.0M | 20.5M | 24.2M | 33.5M | 31.5M |
| Gross Profit | 37.9M | 44.3M | 52.2M | 66.0M | 74.1M |
| Operating Expenses | |||||
| R&D Expense | 5.7M | 6.7M | 8.2M | 11.0M | 9.6M |
| SG&A Expense | 67.0M | 64.8M | 72.3M | 89.9M | 82.0M |
| General & Admin Expense | 28.0M | 36.5M | 41.0M | 49.6M | 40.1M |
| Selling & Marketing Expense | 21.9M | 28.3M | 31.2M | 40.3M | 41.9M |
| Other Expenses | — | — | — | — | (2.8M) |
| Total Operating Expenses | 72.6M | 71.5M | 80.5M | 100.8M | 88.9M |
| Cost and Expenses | 93.6M | 92.0M | 104.7M | 134.4M | 120.4M |
| Operating Income (EBIT) | (34.7M) | (27.2M) | (28.3M) | (34.9M) | (14.8M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 5.1M | 7.7M | 6.9M | 4.6M | 5.0M |
| Net Interest Income | (5.1M) | (7.7M) | (6.9M) | (4.6M) | (5.0M) |
| Other Non-Op Income/Expense | (19.6M) | (20.4M) | (8.8M) | (9.4M) | (8.1M) |
| Non-Operating Income (excl Interest) | 14.5M | 12.7M | 1.9M | 4.9M | 3.1M |
| EBT (Pre-Tax Income) | (54.3M) | (47.6M) | (37.1M) | (44.3M) | (22.8M) |
| Income Tax Expense | 325.0K | (611.0K) | (71.0K) | (722.0K) | (707.0K) |
| Bottom Line | |||||
| Net Income | (54.6M) | (47.0M) | (37.3M) | (43.7M) | (23.0M) |
| Earnings from Cont. Ops | (54.7M) | (47.0M) | (37.0M) | (43.6M) | (22.1M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (54.6M) | (47.0M) | (37.3M) | (43.7M) | (23.0M) |
| Per Share | |||||
| Basic EPS | ($24.84) | ($66.28) | ($6.84) | ($9.91) | ($6.34) |
| Diluted EPS | ($24.84) | ($66.28) | ($6.84) | ($9.91) | ($6.34) |
| Revenue Per Share | $31.67 | $91.44 | $14.03 | $22.63 | $29.09 |
| Shares | |||||
| Basic Shares Outstanding | 1.9M | 709000 | 5.4M | 4.4M | 3.6M |
| Diluted Shares Outstanding | 1.9M | 709000 | 5.4M | 4.4M | 3.6M |
| Profitability Metrics | |||||
| EBITDA | (45.4M) | (36.0M) | (26.1M) | (35.3M) | (13.0M) |
| D&A | 3.8M | 3.9M | 4.1M | 4.5M | 4.9M |
| EBIT | (49.3M) | (39.9M) | (30.2M) | (39.7M) | (17.9M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2025